BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7539485)

  • 21. Inhibitors of acyl CoA:cholesterol acyltransferase.
    Vaccaro W; Amore C; Berger J; Burrier R; Clader J; Davis H; Domalski M; Fevig T; Salisbury B; Sher R
    J Med Chem; 1996 Apr; 39(8):1704-19. PubMed ID: 8648610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Synthesis and hypocholesterolemic activity of dibenz[b,e]oxepin-11-carboxanilides.
    Kumazawa T; Yanase M; Harakawa H; Obase H; Shirakura S; Ohishi E; Oda S; Kubo K; Yamada K
    J Med Chem; 1994 Mar; 37(6):804-10. PubMed ID: 8145231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioisosterism in drug design: identification of and structure-activity relationships in a series of glycine anilide ACAT inhibitors.
    Roark WH; Padia J; Bolton GL; Blankley CJ; Essenburg AD; Stanfield RL; Bousley RF; Krause BR; Roth BD
    Bioorg Med Chem; 1995 Jan; 3(1):29-39. PubMed ID: 8612044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
    Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
    Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rabbit and human liver contain a novel pentacyclic triterpene ester with acyl-CoA: cholesterol acyltransferase inhibitory activity.
    Tabas I; Chen LL; Clader JW; McPhail AT; Burnett DA; Bartner P; Das PR; Pramanik BN; Puar MS; Feinmark SJ
    J Biol Chem; 1990 May; 265(14):8042-51. PubMed ID: 2335515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 6. The first water-soluble ACAT inhibitor with lipid-regulating activity.
    Sliskovic DR; Krause BR; Picard JA; Anderson M; Bousley RF; Hamelehle KL; Homan R; Julian TN; Rashidbaigi ZA; Stanfield RL
    J Med Chem; 1994 Mar; 37(5):560-2. PubMed ID: 8126693
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological properties of YM17E, an acyl-CoA:cholesterol acyltransferase inhibitor, and diarrheal effect in beagle dogs.
    Kashiwa M; Masuyama Y; Miyauchi H; Uchida T; Naganuma S; Kakuta H; Terada M; Kiriyama T; Matsuda K; Ito N; Iizumi Y; Takenaka T
    Jpn J Pharmacol; 1997 Jan; 73(1):41-50. PubMed ID: 9032133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 2. Modification of fatty acid anilide ACAT inhibitors: bioisosteric replacement of the amide bond.
    Roark WH; Roth BD; Holmes A; Trivedi BK; Kieft KA; Essenburg AD; Krause BR; Stanfield RL
    J Med Chem; 1993 May; 36(11):1662-8. PubMed ID: 8496932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of acyl-Coa:cholesterol acyltransferase. 4. A novel series of urea ACAT inhibitors as potential hypocholesterolemic agents.
    Trivedi BK; Holmes A; Stoeber TL; Blankley CJ; Roark WH; Picard JA; Shaw MK; Essenburg AD; Stanfield RL; Krause BR
    J Med Chem; 1993 Oct; 36(22):3300-7. PubMed ID: 8230120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual modulation of hepatic and intestinal acyl-CoA: cholesterol acyltransferase activity by (de-)phosphorylation and substrate supply in vitro.
    Suckling KE; Stange EF; Dietschy JM
    FEBS Lett; 1983 Jan; 151(1):111-6. PubMed ID: 6825835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT). Part 1: identification and structure-activity relationships of a novel series of substituted N-alkyl-N-biphenylylmethyl-N'-arylureas.
    Tanaka A; Terasawa T; Hagihara H; Sakuma Y; Ishibe N; Sawada M; Takasugi H; Tanaka H
    Bioorg Med Chem; 1998 Jan; 6(1):15-30. PubMed ID: 9502102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits.
    Matsui Y; Horiuchi K; Yamamoto K; Kanai K
    Jpn J Pharmacol; 2001 Apr; 85(4):423-33. PubMed ID: 11388647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyunsaturated fatty acid anilides as inhibitors of acyl-coA: cholesterol acyltransferase (ACAT).
    Matsuyama N; Kosaka T; Fukuhara M; Soda Y; Mizuno K
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2039-42. PubMed ID: 10450977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents: synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidates.
    Lee HT; Roark WH; Picard JA; Sliskovic DR; Roth BD; Stanfield RL; Hamelehle KL; Bousley RF; Krause BR
    Bioorg Med Chem Lett; 1998 Feb; 8(3):289-94. PubMed ID: 9871672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 2. Identification and structure-activity relationships of a novel series of N-alkyl-N-(heteroaryl-substituted benzyl)-N'-arylureas.
    Tanaka A; Terasawa T; Hagihara H; Sakuma Y; Ishibe N; Sawada M; Takasugi H; Tanaka H
    J Med Chem; 1998 Jun; 41(13):2390-410. PubMed ID: 9632372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epi-cochlioquinone A, a novel acyl-CoA : cholesterol acyltransferase inhibitor produced by Stachybotrys bisbyi.
    Fujioka T; Yao K; Hamano K; Hosoya T; Kagasaki T; Furukawa Y; Haruyama H; Sato S; Koga T; Tsujita Y
    J Antibiot (Tokyo); 1996 May; 49(5):409-13. PubMed ID: 8682715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma cholesterol reducing effect of FR129169, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in the rat.
    Sakuma Y; Hagihara H; Ohne K; Nagayoshi A; Mutoh S; Ito Y; Notsu Y; Okuhara M
    Jpn J Pharmacol; 1996 Jan; 70(1):35-41. PubMed ID: 8822087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships between lipophilicity and biological activities in a series of indoline-based anti-oxidative acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
    Takahashi K; Kunishiro K; Kasai M; Miike T; Kurahashi K; Shirahase H
    Arzneimittelforschung; 2008; 58(12):666-72. PubMed ID: 19202739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the mechanism of the modulation in vitro of acyl-CoA:cholesterol acyltransferase by progesterone.
    Synouri-Vrettakou S; Mitropoulos KA
    Biochem J; 1983 Oct; 215(1):191-9. PubMed ID: 6626174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitors of acyl-CoA:cholesterol acyltransferase: novel trisubstituted ureas as hypocholesterolemic agents.
    Purchase TS; Essenburg AD; Hamelehle KL; Hes MS; Holmes A; Krause BR; Stanfield RL; Trivedi BK
    Bioorg Med Chem; 1997 Apr; 5(4):739-47. PubMed ID: 9158873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.